MXCT Stock Summary and Trading Ideas (Maxcyte | NASDAQ:MXCT)

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Maxcyte trades on the NASDAQ stock market under the symbol MXCT.

As of July 21, 2026, MXCT stock price climbed to $1.23 with 537,752 million shares trading.

MXCT has a beta of 1.47, meaning it tends to be more sensitive to market movements. MXCT has a correlation of 0.06 to the broad based SPY ETF.

MXCT has a market cap of $131.76 million. This is considered a Micro Cap stock.

Last quarter Maxcyte reported $10 million in Revenue and -$.04 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.05.

In the last 3 years, MXCT traded as high as $5.55 and as low as $.64.

The top ETF exchange traded funds that MXCT belongs to (by Net Assets): VTI, VXF, VHT.

MXCT has underperformed the market in the last year with a price return of -41.4% while the SPY ETF gained +20.2%. However, in the short term, MXCT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +41.3% vs +6.5% return in SPY. But in the last 2 weeks, MXCT shares have been beat by the market, returning -4.7% compared to an SPY return of +0.1%.

MXCT support price is $1.12 and resistance is $1.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MXCT shares will trade within this expected range on the day.